Epilepsy affects around one in every 100 people in the UK and on 26 March you might find out you know one or more of those people but had no idea!
26 March is the international day for epilepsy – known as Purple Day. Epilepsy Society’s mission for Purple Day is to start conversations about epilepsy.
Starting conversations and sharing stories is so important for people with epilepsy and their loved ones. Often epilepsy is a hidden condition and for a variety of reasons people might not talk about their epilepsy. This can make people feel isolated and leave them in the dark about drug options, treatment choices, practical support available to them and much more.
This lack of openness and information is endemic in the history of the drug Sodium Valproate (commonly known as Epilim). Back in 2017, I wrote about the European-wide safety review into Sodium Valproate.
Earlier this year healthcare professionals, including GPs and pharmacists, were reminded to identify and review all women who are taking Sodium Valproate. For many years it has been known that Sodium Valproate increases the risk of a baby born to a mother taking it suffering physical abnormalities and cognitive impairments. Babies exposed to Sodium Valproate in the womb have a 10% chance of developing physical abnormalities and a 4 in 10 chance of developing cognitive problems, such as learning disabilities and autism. Evidence of this risk emerged back in the 1980s, but for years many patients have not been told about the risk.
Even now recent data showed a wide variation in prescribing practices across the UK. Many women are simply not being given the information they are entitled to and the opportunity to discuss the options with their doctor, which puts their unborn child at risk.
Medical professionals are under a duty to take reasonable care to ensure that patients are aware of the material risks involved in recommended treatment and of all reasonable alternative or variant treatments. There are so many different drug and non-drug options now available, so plenty to consider as alternatives to Sodium Valproate. A significant risk is one that would affect the judgment of a reasonable patient. A 10% risk of a baby developing physical abnormalities and a 25% risk of cognitive problems is surely a significant risk that doctors should make all patients aware of so that they can make their own decision about their life and that of the future child.
By starting conversations about epilepsy, we can share information about the condition, how it affects us and issues such as Sodium Valproate. A friendly chat about epilepsy could lead to a woman taking Sodium Valproate learning about risks she didn’t know about and taking steps to protect her unborn child.
So, take the plunge and start the conversation on 26 March. I’ll start the ball rolling a few days early by talking about my epilepsy.
As the saying goes, sharing is caring!
Further information
If you have any questions relating to this ebriefing or epilepsy care, please contact Ann Houghton who will be happy to speak to you on an initial free, no obligation basis.
Epilepsy Society offers a confidential helpline which provides information and emotional support for anyone affected by epilepsy 01494 601 400 and helpline@epilepsysociety.org.uk
Latest news
Staying friends through a split
More couples are choosing to divorce as amicably as possible, demanding an increase for specialist mediation services and less contentious options, such as ‘collaborative law’. But is it really possible to split and stay friends?
Wednesday 19 February 2025
Read moreAnthony Collins reappointed following Cottsway Housing Association tender for housing services
Social purpose law firm, Anthony Collins, has been reappointed as the sole legal provider of housing services for Cottsway Housing Association (Cottsway) tender, continuing a partnership focused on improving communities.
Tuesday 18 February 2025
Read moreLatest webinars and podcasts
Podcast: Leasehold reform: Commonhold
Emma Lloyd and Raj Flora-Seehra explore the Government’s renewed focus on commonhold tenure
Monday 17 February 2025
Read morePodcast: Who gets the microwave? Episode 2 – Non-court dispute resolution
Listen to the second in a series of podcasts from our matrimonial team where Tom Gregory, Chris Lloyd-Smith and Maria Ramon put down their litigation weapons and discuss the importance of […]
Friday 22 November 2024
Read more